Analyst
Vakaria Investment
Equibles does not estimate personal net worth.
Avnish Berman is recorded as Analyst at Vakaria Investment. Avnish Berman has spoken on 1 earnings call across 1 company, most recently for Beta Drugs Limited on October 22, 2026. The companies whose calls Avnish Berman spoke on are classified in the Healthcare sector.
“Raul, you mentioned that the CMO side obviously has seen a step jump in quarterly revenues run rate. One contributor is the NDDS product that you had launched. Is it fair to assume that the margins that you make in this NDDS product on your CMO segment, it will be higher than your average CMO margin?”
Vakaria Investment
Analyst
Transcript header (unverified)
Beta Drugs Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Beta Drugs Limited
